key: cord-0774317-uft02ueo
authors: Ntagereka, Patrick Bisimwa; Oyola, Samuel O.; Baenyi, Simon Patrick; Rono, Gilbert Kibet; Birindwa, Ahadi Bwihangane; Shukuru, Dieudonné Wasso; Baharanyi, Tshass Chasinga; Kashosi, Théophile Mitima; Buhendwa, Jean-Paul Cikwanine; Bisimwa, Parvine Basimane; Kusinza, Aline Byabene; Basengere, Rodrigue Ayagirwe; Mukwege, Denis
title: Whole-Genome Sequencing of SARS-CoV-2 Reveals Diverse Mutations in Circulating Alpha and Delta Variants during the First, Second and Third Waves of Covid-19 in South Kivu, East of the Democratic Republic of Congo
date: 2022-05-20
journal: Int J Infect Dis
DOI: 10.1016/j.ijid.2022.05.041
sha: a5909248119c69801b2e5739cbb12d26160ab10c
doc_id: 774317
cord_uid: uft02ueo

Objectives : Using whole genome sequencing of SARS-CoV-2 to identify variants circulating in DRC and obtaining molecular information useful for diagnosis, improving treatment and general pandemic control strategies. Methods : Seventy-four SARS-CoV-2 isolates were sequenced using Oxford Nanopore platforms. Generated reads were processed to obtain consensus genome sequences. Sequences with over 80% genome coverage were used for variant calling, phylogenetic analysis and classification using pangolin lineage annotation nomenclature. Results : Phylogenetic analysis based on Pangolin classification clustered South Kivu sequences into seven lineages (A.23.1, B.1.1.6, B.1.214, B.1.617.2, B.1.351, C.16 and P.1). The Delta (B.1.617.2) variant was the most dominant and responsible for outbreaks during the third wave. Based on Wuhan reference genome a total of 289 distinct mutations were detected including 141 missenses, 123 synonymous and 25 insertions/deletions when our isolates were mapped to Wuhan reference strain. The majority of these point mutations were located within the coding sequences of the SARS-CoV-2 genome that includes Spike, ORF1ab, ORF3, and nucleocapsid protein (N) genes. The most common mutation was D614G (1841A>G) observed in 61 sequences followed by L4715L (14143C>T) found in 60 sequences. Conclusion : Our findings highlight multiple introductions of SARS-CoV-2 into South Kivu through different sources and subsequent circulation of variants in the province. These results emphasize the importance of timely monitoring of genetic variation and its effect on disease severity. This work set a foundation for the use of genomic surveillance as a tool for future global pandemic management and control.

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is the causative agent of Coronavirus disease 19 (COVID-19) that emerged from China in December 2019 and has spread worldwide including the Democratic Republic of Congo (DRC) causing a global pandemic of unprecedented proportion in the recent past. The adequate clinical course of SARS-CoV-2 infection affects the lung causing flu-like syndrome with clinical signs such as a cough, fever, and in more severe cases, difficulty in breathing (Zou et al., 2020; Ruzzenenti et al., 2021) . 3 Although the pandemic continues, up until now (February 08th 2022), this virus has infected more than 400 million people with more than 5.7 million deaths worldwide (https://www.worldometers.info/coronavirus/). SARS-CoV-2 belongs to the Coronaviridae family, the Betacoronavirus genus, and it is among the largest single-stranded positive-sense RNA viruses. SARS-CoV-2 genome is ~30Kb in length, consisting of 10 open reading frames (ORFs) that codes for ORF1ab polyproteins, spike (S), envelope (E), membrane (M), nucleocapsid (N), and other accessory proteins (Tai et al., 2020; Lu et al., 2020; Bar-On et al., 2020) . Among the genes, S glycoprotein plays essential roles in virus attachment, fusion, and entry into the host cell by binding with angiotensin-converting enzyme 2 (ACE2) receptor (Tai et al., 2020) and eliciting protective humoral and cell-mediated immune responses in hosts during infection (Belouzard et al., 2012; Amanat et al., 2020) .

To date, SARS-CoV-2 isolates have been classified into eleven clades based on GISAID nomenclature. These clades include L (the clade to which the Wuhan reference strain belongs), S, V, G, GH, GK, GR, GV, O, S and V (Hamed et al., 2021) .

The first COVID-19 case was reported in DRC on March the 10 th , 2020, in Kinshasa the capital city (WHO, 2020) . Since then, the disease has spread rapidly across the country including South Kivu Province and as expected, outbreak dynamics differ among provinces.

Subsequently, a countrywide partial lockdown that led to schools, and international boundaries closures was imposed by the government from April 2020 to August 2020. Despite, the enforcement of these preventive measures, the number of COVID-19 cases and deaths continued to increase. This led to the first wave of local transmission between March and August 2020. The partial lockdown was vacated where schools and other activities resumed from September 2020. However, in December 2020, another wave of COVID-19 infection hit the country, peaking in February-March 2021. As a result, new containment measures such as curfew, closing of school and abolition of social gatherings, mandatory wearing of face masks as well as proof of a negative polymerase chain reaction (PCR) test for international travelers upon arrival were enforced.

Similarly, from June to September 2021, an exponential increase of COVID-19 cases were reported across the country; this culminated in to the third wave of infection. The situation deteriorated very fast particularly in South Kivu province where cases quadrupled, compared to previous waves where an average of 30 cases were reported per week. In the third wave, up to 320 infection cases and ~10 deaths per week were reported. This placed the South Kivu among the top four provinces that were most affected by COVID-19 pandemic. A total of 2712 infection cases and 58 deaths were recorded in South Kivu by January the 14 th 2022, out of a total of 83194 cases and 1086 deaths reported countrywide. Variability was observed within and between waves in number of infected people and the severity of the disease in affected patients.

This may indicate variant strains that may be in circulation.

Genomic surveillance is an important tool for global epidemic control by enabling monitoring, evolution, tracking the spread and investigating multiple introductions of the virus (Fraser et al., 2009; Gardy et al., 2018; Holshue et al., 2020) . To understand SARS-CoV-2, transmission dynamics and circulating variants, whole-genome sequencing has proven to be a critical epidemiological tool.

To date, few studies on genomic characterization of SARS-CoV-2 circulating in Congolese population have been reported and the little available information is restricted to Kinshasa, the capital city of the country. However, no information is available on SARS-CoV-2 variants circulating in the eastern part of DRC.

South Kivu province is of special interest owing to its geographical location. It borders several countries including Burundi, Rwanda and Tanzania. The Province consists of a mixed population from different countries bordering DRC and may favor the introduction and circulation of different SARS-CoV-2 lineages. This study reports the complete genome sequences and phylogenetic analysis of seventy-four SARS-CoV-2 isolates from the first, second and third waves of the epidemic in South Kivu province, East of DRC. 

The viral RNA was extracted from nasopharyngeal swabs using the QIAamp Viral RNA Mini kit (Qiagen, Hilden, Germany) following the manufacturer's instructions. The cDNA library was constructed using FIREScript® RT cDNA synthesis KIT (Solis, Biodyne, Italie)

following the manufacturer's instructions. Briefly, 1µl of the total RNA was added into 5µl of 6 the 5x cDNA synthesis mix containing 1µl of SOLIScript Reverse Transcriptase, 0.5ul of RiboFrip RNase Inhibitor, 2µl of 10x RT Reaction Buffer with 10mM DTT, 1µl of random hexamers primers and 0.5µl dNTP mix. The volume was brought up to 20µl with nuclease-free water.

The reactions were incubated for 10 min at 25°C followed by 30 min at 60°C for reverse transcription and 5 min at 85°C for enzyme activation. These steps were carried out in a thermocycler machine (ProFlex, PCR system, Applied Biosystems). The cDNA samples obtained were then stored at −20°C until further use.

Library preparation and high throughput genomic sequencing was performed at the ILRI Genomic Platform (Nairobi, Kenya). SARS-CoV-2 whole genome sequencing was carried out as described previously (Gohl et al., 2020) . Briefly, viral RNA extraction was performed using TANBead® Maelstrom 9600 (Taiwan Advanced Nanotech Inc, Taiwan) automated nucleic acid extractor following the manufacturer's directions. RNA was eluted in 60µl buffer and stored in RNAse-free Eppendorf tubes. The ARTIC SARS-CoV-2 Library Prep Kit (ONT®) were used follozing workflows for Oxford Nanopore Technology (ONT) (Grubaugh et al., 2019) . ONT sequencing was done on the MinION platform. Basecalling, demultiplexing, and adapter trimming were performed using Guppy v5.0.11 and fastq outputs used for downstream analyses.

From the 130 sequenced samples only 74 were considered for the downstream analysis, and 56 sequences were removed as we could assemble only 70% to the SARS-CoV-2 reference genome.

Variant calling and lineage/clade assignment were carried out using the singularity container of the nf-core/viralrecon v2.2: an analysis pipeline for assembly and intra-host/lowfrequency variant calling for viral samples (https://github.com/nf-core/viralrecon/releases). Read mapping and consensus generation were done by minimap2, and medaka was employed for mutation calling, The snpEff was used for mutation annotation. Pangolin USHER was used further downstream in the analysis of consensus sequences for lineage assignments based on parsimony and Nextclade (Hadfield et al., 2018) for clade specification. The sequence statistics generated from this study are presented in supplementary material Table 1 .

A total of 399 SARS-CoV-2 reference sequences subsampled by Nextstrain were retrieved from NCBI and included in the analysis. These genome sequences were filtered to remove sequences with no metadata and those with greater than 1% of ambiguous bases and partial genomes of less than 80% genome coverage. The subsampling of the reference genomes was done using nextrain's command-line Augur filter tool based on an already subsampled dataset of 2867 that were evenly distributed across time and geography. Our subsampling ensured that we include only genomes with key metadata such as pangolin lineages, sampled before August 31st 2021, from a human host and further probabilistic sampling to minimise any bias. The tree was generated through nextclades's command line workflow and visualised using a local Auspice installation. The nexus tree was downloaded and further edited in figtree tool.

Phylogenetic relationships were inferred using IQtree/1.6.8 with 1000 bootstrap iterations. The tree was further visualized with FigTree/1.4.4. SARS-CoV-2 pangolineages were assigned using pangolin 3.1.14 (pangoLEARN version 2021-10-13). Nextclade CLI 1.4.2 tool (Aksamentov, 2021 ) was used to assign SARS-CoV-2 "Nextstrain clades" to the genomes based on predetermined mutations.

Clinical characteristics of the 74 tested patients and Pango lineage distribution 8 A total of fifty-seven samples (77%) were from male patients within the age range of 31 to 50 years (51.3%). Most patients presented severe symptoms at admission (fever, headache, cough, difficulty in breathing, dyspnea) (n=38(51.3%)) followed by asymptomatic cases (n=31(41.9%)). Diabetes was the major chronic comorbidity presenting in 33(44.6%) patients followed by hypertension in 21(28.3%) patients (Table 1) patients. The majority were young patients within the age range of 31-50years (n=18(62%)), over half asymptomatic (n=16(55.2%)), and more than half (n=15(51.2%)) were diabetic.

Interestingly, 20(68.9%) of these patients were admitted in hospitals. Demographic and epidemiological characteristics of patients infected with SARS-CoV-2 categorized by the PANGO nomenclature are summarized in Table 1 .

Phylogenetic analysis revealed the presence of two major SARS-CoV-2 Variants of (Table 3) . Of the missense mutations, 71 were identified in ORF1ab the longest ORF of SARS-CoV-2 covering roughly two-thirds of the entire genome. Spike gene had 31 missense mutations. Similarly, the majority (90) of synonymous mutations were found in the ORF1ab, followed by 12 synonymous mutations located in the Spike region.

Mutations with a frequency of more than ten sequences are reported in Table 4 . The most frequent mutations identified were the missense mutation D614G in S gene found in 61 sequences and the synonymous mutation L4715L in the ORF1ab gene observed in 60 sequences.

Additionally, a synonymous mutation F53F in the N gene was found in 32 sequences, missense mutations S26L and T120I in ORF3a and ORF7a respectively were found in 27 sequences. A missense mutation I82T and a synonymous mutation V75V (225C>T) were the most common in gene M and E respectively.

A genome constitutes the molecular architecture of any living organism and encodes its phenotypic and genotypic make-up. Mutations in the SARS-CoV-2 genome play a vital role in the virus genome transmission, replication efficiency, pathogenicity, and virulence for its human host (Maitra et al., 2020) . The present study describes molecular characteristics and analysis of the mutation pattern of full-length SARS-CoV-2 strains responsible for COVID-19 epidemics in South Kivu province, DRC, from December 2020 to July 2021. We have elucidated the circulating variants and possible resultant effects of mutations identified in infected individuals.

In the current study, Pango analysis of 74 samples clustered the SARS-CoV-2 sequences in 4 main Pangolin lineages with the most prevalent being the B.1.617.2 primarily identified in young male individuals as well as A.23.1 and B.1.351 (VOC). A previous studies conducted in Rwanda (Butera et al., 2021) and Uganda (Bugembe et al., 2021) reported the sub-lineage A.23.1 that is currently dominating and detection of lineage B.1.315 among incoming travelers.

Our analyses show that most of tested samples were from diabetic patients and about a quarter were from hypertensive individuals. These findings corroborate with previous studies suggesting that comorbidities play a significant role in COVID-19 disease severity (Goyal et al., 2020; Richardson et al., 2020) . The B.1.617.2 was primarily detected mostly in patients with severe symptoms and the majority were admitted in hospitals. This finding is in line with previous studies that demonstrated that patients with the delta variant of SARS-CoV-2 are more than twice as likely to be admitted to hospital than those infected with the alpha or gamma variants (Wise, 2021; Twohig et al., 2021) . The third wave was characterized by an increase in COVID-19 cases and deaths in DRC particularly in South Kivu compared to the previous waves where an average of 320 cases and 10 deaths were recorded daily. The Delta reportedly originated from the state of Maharashtra in late 2020 and spread throughout India (Mlcochova et al., 2021) .

The Delta variant spread throughout DRC and led to more severe disease symptoms in the local population with many hospitalization cases. This is in line with previous studies showing the Delta variant to be the most dominant strain worldwide, more transmissible and presenting a higher risk of hospitalization and mortality (Callaway, 2021; Despress et al., 2021) .

Delta variant was declared a variant of concern due to this characteristic (Singh et al. 2021 ).

In addition, the Beta (B.1.351) variant was also responsible for outbreaks during the first and second waves in South Kivu. The presence of the Beta variant was first reported in India during December 2020 before it spreads in Africa particularly in South Africa with 8,664,388 cases reported in the continent. This variant was associated with in-hospital mortality in the second wave in South Africa (Tegally et al., 2021) . Beta is also a variant of concern and a highly transmissible SARS CoV-2 variant (Yadav et al. 2021) .

Two other variants of interest such as A.23.1 and B.1.214 were also identified in this study. These variants were responsible for most of outbreaks in neighboring countries such as the Republic of Rwanda (Butera et al., 2021) and Uganda (Bugembe et al., 2021) human host and may lead to observed variations in pathogenicity of the virus. This agrees with a previous study reporting recurrent mutations in the same SARS-CoV-2 genome targets in the African population (Omotoso et al., 2021) . Additionally, a similar study has shown that most of mutations are found within the ORF1ab, S and N genes of the SARS-CoV-2 genome (Wang et al., 2020; Kim et al., 2020) .

Our study shows a higher number of missense mutations than synonymous mutations and half of them were located in the ORF1ab gene followed by the spike gene (49 missense mutations). A similar observation was reported in studies conducted in Colombia and Egypt (Bermúdez et al., 2021; Erdem et al., 2021; Zekri et al., 2021; Maitra et al., 2020) . Interestingly, the L4715L mutation found in 60 SARS-CoV-2 sequences from this study corroborates with previous findings reporting the P4715L mutation as a potential antiviral drug target (Pachetti et al., 2020) .

Mutation analysis further showed many number of samples with D614G mutation in the spike glycoprotein (1841A>G) flagging this position as a SARS-CoV-2 mutation hotspot. A previous study has reported the same mutation in high number of sequences in Turkey and it has gradually become dominant in the world (Erdem et al. 2021) . Additionally, the D614G mutation in the SARS-CoV-2 spike protein has been associated with increases infectivity and transmissibility (Lizhou et al., 2020) .

N gene encoding the nucleocapsid protein plays an important role in RNA packaging and the release of viral particles (Zeng et al., 2020) . The most frequent mutation in this gene reported globally is the R203K, but it was shown not to affect the protein function. However, the R203K mutation was not found in our study; instead, we identified the R203M (608G>T) mutation whose functional impact is still unknown.

14 Several insertions/deletion mutations were in some of the sequences in this study even though further confirmation is required. However, these mutations would imply modification of the gene (protein) of concern and, therefore may affect the adaptability and or pathogenicity of the virus. Other point mutations that have not been reported before were also identified in many sequences. We can speculate a correlation between these genetic changes and virus adaptation because these mutations are never fixed in the population.

This study analyzed SARS-CoV-2 whole genomes from 74 Congolese samples during the first, second and third waves. Two lineages including Delta (B.1.617.2) and Beta (B.1.351) were identified to be circulating with several mutations in coding genes. Delta was the most abundant of these lineages, especially during the third wave, causing most of the COVID-19 deaths in South Kivu from May to end July 2021. We cannot assume the possibility that the simultaneous circulation of these two SARS-CoV-2 variants could have exacerbated the transmissibility potential of the virus and thus caused devastating infections in this densely populated region. Our results further highlight a need for regional collaborations for a durable response towards combating COVID-19.

The study protocol was approved by the Interdisciplinary Center of Ethical Research 

The sequences of complete viral genomes are available online through GISAID (http://gisaid.org) and can be found on the supplementary material table 2. The datasets generated and analyzed during the current study are also available from the corresponding author on request.

Patrick Bisimwa Ntagereka, study's design, data collection, drafting manuscript.

Samuel O. Oyola, sequence analysis and drafting manuscript.

Simon Baenyi Patrick, data collection and reviewing manuscript.

Gilbert Kibet Rono, study design and sequence analysis.

Ahadi Bwihangane Birindwa, study design and reviewing manuscript.

Dieudonne Wasso Shukuru, study conceptualization and data analysis.

Tshass Chasinga Baharanyi, drafting initial manuscript and reviewing manuscript.

Théophile Mitima Kashosi, data collection, drafting manuscript.

Jean-Paul Chikwanine Buhendwa, study design and data collection.

Parvine Basimane Bisimwa, study design and reviewing manuscript. 

SARS-CoV-2 Vaccines: Status Report

SARS-CoV-2 (COVID-19) by thenumbers

Mechanisms of coronavirus cell entry mediated by the viral spike protein

Mutation profile of SARS-CoV-2 genome in a sample from the first year of the pandemic in Colombia

A SARS-CoV-2 lineage A variant (A. 23.1) with altered spike has emerged and is dominating the current Uganda epidemic

Genomic sequencing of SARS-CoV-2 in Rwanda reveals the importance of incoming travelers on lineage diversity

Genomic characterization of SARS-CoV-2 isolates from patients in Turkey reveals the presence of novel mutations in spike and nsp12 proteins

Molecular epidemiology surveillance of SARS-CoV-2: mutations and genetic diversity one year after emerging

WHO Rapid Pandemic Assessment Collaboration

Towards a genomics-informed, real-time, global pathogen surveillance system

A rapid, cost-effective tailed amplicon method for sequencing SARS-CoV-2

Clinical Characteristics of Covid-19 in New York City

An amplicon-based sequencing framework for accurately measuring intrahost virus diversity using PrimalSeq and iVar

Nextstrain: real-time tracking of pathogen evolution

Global dynamics of SARS-CoV-2 clades and their relation to COVID-19 epidemiology

First case of 2019 novel coronavirus in the United States

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 shedding and increases infectivity

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

Mutations in SARS-CoV-2 viral RNA identified in Eastern India: possible implications for the ongoing 19

India and impact on viral structure and host susceptibility

.617.2 Delta variant replication and immune evasion

Mutational hotspots and conserved domains of SARS-CoV-2 genome in African population

Whole Genome Sequencing of SARS-CoV-2 Strains in COVID-19 Patients From Djibouti Shows Novel Mutations and Clades Replacing Over Time

Emerging SARS -CoV -2 mutation hot spots include a novel RNA -dependent -RNA polymerase variant

Releases·nf-core/viralrecon

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the

Covid and Cardiovascular Diseases: Direct and Indirect Damages and Future Perspective

Characterization of the receptor-binding domain(RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Rapid replacement of the Beta variant by the Delta variant in South Africa. medRxiv and bioRxiv

COVID-19 Genomics UK (COG-UK) consortium. Hospital admission and emergency care attendance risk for SARS-CoV-2 delta (B.1.617.2) compared with alpha (B.1.1.7) variants of concern: a cohort study

Whole-genome sequencing of SARS-CoV-2 reveals the detection of G614 variant in Pakistan

Covid-19: Delta variant doubles risk of hospital admission compared with alpha variant, study shows

First case of COVID-19 confirmed in the Democratic Republic of the Congo

Characterization of the SARS-CoV-2 genomes in Egypt in first and second waves of infection

SARS-CoV-2 viral load in upper respiratory specimens of infected patients

Aline Byabene Kusinza, data collection design and reviewing manuscript.Rodrigue Ayagirwe Basengere, data collection supervision and reviewing manuscript.Denis Mukwege, study supervision and reviewing manuscript.All authors approved the manuscript.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

We Acknowledge the Université Evangélique en Afrique (UEA) through the Bioscience unit and German Institute for Medical Mission (DIFÄM) for the financial support. Our sincere appreciation goes further to the Provincial Ministry of Health and all the health structure leaders to facilitate access to samples and data. We also appreciate the lab technicians of the Molecular Biology laboratory of UEA for their technical support.